Systemic hypertension and coronary artery disease: The link

American Journal of Cardiology

Volumn 82, Issue 3 A, 1998, Pages 2-7

  Lembo, Giuseppe ^b   Morisco, Carmine ^a   Lanni, Francesca ^a   Barbato, Emanuele ^a   Vecchione, Carmine ^a   Fratta, Luigi ^a   Trimarco, Bruno ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b IRCCS NEUROMED   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BODY WEIGHT; CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; CORONARY RISK; DYSLIPIDEMIA; GLUCOSE INTOLERANCE; HUMAN; HYPERINSULINEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; FIBROSIS; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; INSULIN RESISTANCE; OXYGEN SUPPLY; VASODILATATION;

BETA ADRENERGIC RECEPTOR; NORADRENALIN;

EID: 0031722174     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00484-6     Document Type: Conference Paper

References (59)

1. MacMahon S., Peto R., Cutler J., Collins R., Sorlie P., Neaton J., Abbott R., Godwin J., Dyer A., Stamler J. Blood pressure, stroke, and coronary heart disease, part I effects of prolonged differences in blood pressure. Evidence from nine prospective observational studies corrected for the regression dilution bias . Lancet. 335:1990;765-774.
2. Standgaard S., Haunso S. Why doeas antihypertensive treatment prevent stroke but not myocardial infarction? Lancet. ii:1987;658-660.
3. Collins R., Peto R., MacMahon S., Hebert P., Fiebach N.H., Eberlein K.A., Godwin J., Qizilbash N., Taylor J.O., Hennekens C.H. Blood pressure, stroke and coronary heart disease, part II effects of short-term reductions in blood pressure. An overview of the unconfounded randomized drug trials in their epidemilogical context . Lancet. 335:1990;827-838.
4. Kannel W.B., Dauenberg A.L., Levy D. Population implications of electrocardiographic left ventricular hypertrophy. Am J Cardiol. 60:1987;851-931.
5. Levy D., Garrison R.J., Savage D.D., Kannel W.B., Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med. 322:1990;1561-1566.
6. Muiesan M.L., Salvetti M., Rizzoni D., Castellano M., Donato F., Agabiti-Rosei E. Association of change in left ventricular mass with prognosis during longterm antihypertensive treatment. J Hypertens. 13:1995;1091-1097.
7. Burke A.P., Farb A., Liang Y.H., Smialek J., Virmani R. Effect of hypertension and cardiac hypertrophy on coronary artery morphology in sudden cardiac death. Circulation. 94:1996;3138-3145.
8. Stauer B.E. Ventricular function and coronary hemodynamics in hypertensive heart disease. Am J Cardiol. 44:1979;999-1006.
9. Weber K.T., Brilla C.G. Pathological hypertrophy and the cardiac interstitium. Fibrosis and the renin-angiotensin-aldosterone system. Circulation. 83:1991;1849-1865.
10. Stauer B.E. Myocardial oxygen consumption in chronic heart disease role of wall stress, hypertrophy and coronary reserve . Am J Cardiol. 44:1979;730-740.
11. van Hoeven K.H., Factor S. Endomyocardial biopsy diagnosis of small vessel disease a clinical study . Int J Cardiol. 26:1990;103-110.
12. Schwartzkopff B., Motz W., Knauer S., Frinzel H., Strauer B.E. Morphometric investigation of intramural coronary arteries from right septal endomyocardial biopsy in patients with hypertensive heart disease. Mulvany M.I., Aalkjaer C., Heagerty A.M., Nyborg N.C.B., Strandgaard S. Resistance Arteries, Structure and Function. 1991;305-307 Excerpta Medica, Amsterdam/New York/Oxford.
13. Opherk D., Mall G., Zebe H., Schwarz F., Weihe E., Manthey J., Kubler W. Reduction of coronary reserve a mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries . Circulation. 69:1984;1-7.
14. Bishop S.P., Powell P.C., Hasebe N., Shen Y.T., Patrick T.A., Hittinger L., Vatner S.F. Coronary vascular morphology in pressure-overload left ventricular hypertrophy. J Mol Cell Cardiol. 28:1996;141-154.
15. Treasure C.B., Klein J.L., Vita J.A., Manoukian S.V., Renwick G.H., Selwyn A.P., Ganz P., Alexander R.W. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 87:1993;86-93.
16. Antony I., Aptecar E., Lerebours G., Nitenberg A. Coronary artery constriction caused by the cold pressure test in human hypertension. Hypertension. 24:1994;212-219.
17. Nabel E.G., Ganz P., Gordon J.B., Alexander R.W., Selwyn A.P. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation. 77:1988;43-52.
18. Houghton J.L., Smith V.E., Strogatz D.S., Henches N.L., Breisblatt W.M., Carr A.A. Effect of African-American race and hypertensive left ventricular hypertrophy on coronary vascular reactivity and endothelial function. Hypertension. 29:1997;706-714.
19. Feigl E.O. Carotid sinus reflex control of coronary flow. Circ Res. 23:1968;223-237.
20. Vatner S.F., Franklin D., Van Citters R.L., Braunwald E. Effects of carotid stimulation on the coronary circulation of the conscious dog. Circ Res. 27:1970;11-21.
21. Mark A.L., Abboud F.M., Schmid P.G., Heistad D.D. Reflex vascular response to left ventricular outflow obstruction and activation of ventricular baroreceptors in dogs. J Clin Invest. 2:1973;1147-1153.
22. Zelis R., Lotysh M., Brais M., Peng C.L., Hurley E., Mason D.T. Effects of isolated right atrial and left ventricular stetch on regional arteriolar resistance. Cardivasc Res. 11:1977;419-426.
23. Trimarco B., Chierchia S., Lembo G., De Luca N., Ricciardelli B., Condorelli G., Volpe M., Condorelli M. Prolonged duration of myocardial ischemia in patients with coronary heart disease ind impaired cardiopulmonary baroreceptor sensitivity. Circulation. 81:1990;1792-1802.
24. Trimarco B., Lembo G., De Luca N., Volpe M., Ricciardelli B., Condorelli G., Rosiello G., Condorelli M. Blunted sympathetic response to cardiopulmonary receptor unloading in hypertensive patients with left ventricular hypertrophy. A possible compensatory role of atrial natriuretic factor. Circulation. 80:1989;883-892.
25. Trimarco B., De Luca N., De Simone A., Volpe M., Ricciardelli B., Lembo G., Condorelli M. Impaired control of arginine vasopressin release by cardiopulmonary receptors in hypertensive patients with left ventricular hypertrophy. Hypertension. 10:1987;595-602.
26. Luscher T.F., Vanohutte P.M. The Endothelium Modulator of Cardiovascular Function . 1990;CRC Press, Boca Raton.
27. Palmer R.J.M., Ashtor D.S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 333:1988;664-666.
28. Lorenzi M., Cagliero E. Pathobiology of endothelial and other vascular cells in diabetes mellitus call for data . Diabetes. 40:1991;653-659.
29. Jensen T., Bjerre-Knudsen J., Feldt-Rasmussen B., Decker T. Features of endothelial dysfunction in early diabetic nephropathy. Lancet. 1:1989;461-463.
30. Guerra S., Brotherton A.F.A., Goodwin P.J., Clark C.R., Armstrong M.L., Harrison D.G. Mechanisms of abnormal endothelium-dependent vascular relaxation in atherosclerosis implications for altered autocrine and paracrine functions of EDRF . Blood Vessels. 26:1989;300-314.
31. 2 formation and platelet sensitivity to prostacyclin in insulin-dependent and independent diabetics. Thromb Res. 26:1982;359-370.
32. Tesfamariam B., Brown M.L., Deykin D., Cohn R.A. Elevated glucose promotes generation of endothelium-derived vasoconstrictor prostanoids in rabbit aorta. J Clin Invest. 85:1990;929-932.
33. DiCorleto PE, Fox PL. Growth factor production by endothelial cells. Endothelial Cells. Boca Raton: CRC Press 1988;2:51-62.
34. Haller H. Modulation of endothelial function strategy for long-term cardiovascular protection . J Hypertens. 14:(suppl 4):1996;S27-S32.
35. Konishi M., Su C. Role of endothelium in dilator responses of spontaneously hypertensive rats. Hypertension. 5:1983;881-886.
36. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
37. Taddei S., Virdis A., Mattei P., Salvetti A. Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension. 21:1993;929-933.
38. Rees D.D., Palmer R.M., Moncada S. The role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
39. Vallace P., Collier J., Moncada S. Effects of endothelium derived nitric oxide on peripheral arteriolar tone in man. Lancet. ii:1989;997-1000.
40. Bieirwaltes W.H. Nitric oxide participates in calcium-mediated regulation of renin release. Hypertension. 23:(suppl I):1994;I40-I44.
41. Boulanger C.M., Luscher T.F. Release of endothelin from the porcine aorta; inhibition by endothelium-derived nitric oxide. J Clin Invest. 85:1990;587-590.
42. Biondi M.L., Dousa T., Vanhoutte P.M., Romero J.C. Evidences for the existence of endothelium-derived relaxing factor in the renal medulla. Am J Hypertens. 3:1990;876-879.
43. Ruilope L.M., Lahera V., Rodicio J.L., Romero J.C. Participation of nitric oxide in the regulation of renal function possible role in the genesis of arterial hypertension . J Hypertens. 12:1994;625-631.
44. Sander M., Hansen P.G., Victor R.G. Sympathetically mediated hypertension caused by chronic inhibition of nitric oxide. Hypertension. 26:1995;691-695.
45. Luscher T.F., Raij L., Vanohutte P.M. Endothelium-dependent vascular responses in normotensive and hypertensive Dahl-rats. Hypertension. 9:1987;157-163.
46. Luscher T.F., Romero J.C., Vanhoutte P.M. Bioassay of endothelium-derived vasoactive substances in the aorta of normotensive and spontaneously hypertensive rats. J Hypertens. 4:(suppl 6):1987;S81-S83.
47. Luscher T.F., Vanhoutte P.M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rats. Hypertension. 8:1986;344-348.
48. DeFronzo R.A., Ferranini E. Insulin resistance a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease . Diabetes Care. 14:1991;173-194.
49. Reaven G.M. Banting Lecture. Role of insulin resistance in human disease. Diabetes. 37:1988;1595-1607.
50. Després J.P., Lamarche B., Mauriége P., Cantin B., Dagenais G.R., Moorjani S., Lupien P.J. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med. 334:1996;952-957.
51. Zimlichman R., Zeidel L., Gefel D., Barg J., Shahar C., Nakash Y., Matas Z., Gass S., Eliahou H.E. Insulin induces medial hypertrophy of myocardial arterioles in rats. Am J Hypertens. 8:1995;915-920.
52. Julius S., Jamerson K., Mejia A., Krause L., Schork N., Jones K. The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure Study. JAMA. 264:1990;354-358.
53. Piédrola G., Novo E., Serrano-Gotarredona J., Escobar-Morreale H.F., Villa E., Luna J.D., Garcia-Robles R. Insulin resistance in patients with a recent diagnosis of coronary artery disease. J Hypertens. 14:1996;1477-1482.
54. Anderson E.A., Hoffman R.P., Balon T.W., Sinkey C.A., Mark A.L. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 87:1991;2246-2252.
55. Lembo G., Napoli R., Capaldo B., Rendina V., Iaccarino G., Volpe M., Trimarco B., Sacca L. Abnormal sympathetic overactivity evoked by insulin in the skeletal muscle of patients with essential hypertension. J Clin Invest. 90:1992;24-29.
56. 2-adrenergic pathway in humans. Hypertension. 24:1994;429-438.
57. Lembo G., Iaccarino G., Vecchione C., Rendina V., Parrella L., Trimarco B. Insulin modulation of β-adrenergic vasodilator pathway in human forearm. Circulation. 93:1996;1403-1410.
58. 2-adrenergic vasorelaxation by a pertussis toxin mechanism. Hypertension. 30:1997;1128-1134.
59. 2- and β-adrenergic responses in human forearm. J Clin Invest. 1997;2007-2014.